AUTUMN VENTURELLI: Open Payments
NPI 1376208033 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,167 in 117 payments from 17 companies in 2025. Trend: 2023 $1,059 · 2024 $1,580 · 2025 $2,167
Food & beverage: $2,167
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $758 |
| QOL Medical, LLC | 10 | $319 |
| Janssen Biotech, Inc. | 22 | $292 |
| Ardelyx, Inc. | 11 | $164 |
| Regeneron Healthcare Solutions, Inc. | 4 | $112 |
| Madrigal Pharmaceuticals | 5 | $95 |
| Phathom Pharmaceuticals, Inc. | 6 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Gilead Sciences, Inc. | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
Products named: RINVOQ, Sucraid, TREMFYA, IBSRELA, DUPIXENT, LINZESS, SKYRIZI, CREON.
Industry payments across GA — which companies pay providers there.
